Author:
Johnson Drusus A.,Hogan Megan,Marriot Ray,Heaney Liam M.,Bailey Stephen J.,Clifford Tom,James Lewis J.
Abstract
Abstract
Background
Cannabidiol (CBD)-containing products are sold widely in consumer stores, but concerns have been raised regarding their quality, with notable discrepancies between advertised and actual CBD content. Information is limited regarding how different types of CBD products may differ in their deviation from advertised CBD concentrations. Therefore, CBD concentrations were quantified and compared in aqueous tinctures, oils, e-liquids and drinks.
Methods
Products (13 aqueous tinctures, 29 oils, 10 e-liquids and 11 drinks) were purchased online in the UK. CBD concentrations were quantified in aqueous tinctures, oils and e-liquids via high performance liquid chromatography (HPLC), and in drinks via gas chromatograhy-mass spectrometry (GC-MS).
Results
Measured concentrations fell −25.7 ± 17.3, −6.1 ± 7.8, −6.9 ± 4.6 and − 0.03 ± 0.06 mg/mL below advertised concentrations for aqueous tinctures, oils, e-liquids and drinks, respectively (medians ± interquartile ranges; p < .05). Oils deviated relatively less (−19.0 ± 14.5%) from advertised concentrations than e-liquids (−29.2 ± 10.2%), aqueous tinctures (−51.4 ± 41.4%) and drinks (−65.6 ± 36.5%; p < .01), whilst e-liquids deviated less than aqueous tinctures and drinks (p < .05), and deviation was not different between aqueous tinctures and drinks (p = .19). Only 5/63 (8%) products had measured concentrations within 10% of advertised concentrations.
Discussion
Similarly to previous studies, few products had measured CBD concentrations within 10% of advertised concentrations, with most falling below advertised concentrations. All individual product types deviated from advertised concentrations, with oils deviating least. These findings may be indicative of poor manufacturing standards, or that CBD undergoes degradation in consumer products. This reinforces concerns over quality of CBD-containing consumer products and may highlight the need for improved regulation of such products.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmacology,Health (social science)
Reference14 articles.
1. Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318(17):1708–9. https://doi.org/10.1001/jama.2017.11909.
2. Community Research and 2CV: Consumer Research Report on Cannabidiol (CBD) Extracts. Food Standards Agency. 2019. https://www.food.gov.uk/sites/default/files/media/document/cbd-consumer-research-report-october-2019_0.pdf. Accessed 20 July 2021.
3. Grafinger KE, Krönert S, Broillet A, Weinmann W. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland. Forensic Sci Int. 2020;310:110261.https://doi.org/10.1016/j.forsciint.2020.110261.
4. Gurley BJ, Murphy TP, Gul W, Walker LA, ElSohly M. Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi. J Diet Suppl. 2020;17(5):599–607. https://doi.org/10.1080/19390211.2020.1766634.
5. Kosović E, Sýkora D, Kuchař M. Stability study of cannabidiol in the form of solid powder and sunflower oil solution. Pharmaceutics. 2021;13(3):412. https://doi.org/10.3390/pharmaceutics13030412.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献